Effects of sleeve gastrectomy on liver enzymes, non-alcoholic fatty liver disease-related fibrosis and steatosis scores in morbidly obese patients: first year follow-up

Creative Commons License

Aksoy E. K., GÖKTAŞ Z., Albuz O., Akpinar M. Y., Ozturk D., Bulus H., ...More

JOURNAL OF LABORATORY MEDICINE, vol.43, no.2, pp.115-122, 2019 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 43 Issue: 2
  • Publication Date: 2019
  • Doi Number: 10.1515/labmed-2018-0181
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.115-122
  • Keywords: non-alcoholic fatty liver disease, obesity, sleeve gastrectomy, BARIATRIC SURGERY, WEIGHT-LOSS, STEATOHEPATITIS, EPIDEMIOLOGY, NAFLD
  • Hacettepe University Affiliated: Yes


Background: Non-alcoholic fatty liver disease (NAFLD) has a high prevalence among patients undergoing laparoscopic sleeve gastrectomy (LSG). Although liver biopsy is the gold standard for assessing histopathologic changes in the liver, it is an invasive procedure. The objective of this study was to evaluate the effect of sleeve gastrectomy on liver enzymes, fibrosis and steatosis scores; ultrasonographic findings; biochemical parameters; and anthropometric measurements in morbidly obese patients with NAFLD.